Pharmacology, Toxicology and Pharmaceutical Science
Medulloblastoma
100%
Neuroblastoma
72%
Neoplasm
64%
Malignant Neoplasm
54%
Mouse
38%
Tumor Growth
36%
Temsirolimus
32%
Nanoparticle
25%
Small Interfering RNA
23%
Breast Tumor
21%
Polyethylene Glycol
21%
STAT3 Protein
15%
Chemotherapy
14%
Dicer
13%
Nanomedicine
13%
Breast Cancer
12%
Hedgehog
12%
Blood-Brain Barrier
11%
Solid Malignant Neoplasm
11%
Cisplatin
11%
IC50
11%
Drug Resistance
10%
Combination Therapy
10%
Cyclin Dependent Kinase
10%
Copolymer
10%
Preclinical Study
9%
Triple Negative Breast Cancer
9%
Receptor
9%
Juvenile Myelomonocytic Leukemia
9%
Biological Marker
9%
Chemokine
9%
Anticarcinogen
9%
Hodgkin Disease
9%
Apolipoprotein
9%
microRNA 21
9%
Histone Deacetylase
9%
Complexation
9%
Carbamic Acid
9%
Immunotherapy
9%
Drug Delivery System
9%
Rapamycin
9%
Antimalarial Agent
9%
Ozonide
9%
Protein Inhibitor of Activated STAT
9%
Cyclin Dependent Kinase 9
9%
Langerhans Cell Histiocytosis
9%
Juvenile Xanthogranuloma
9%
Clofarabine
9%
Untranslated RNA
9%
Cycline
8%
Medicine and Dentistry
Ganglioneuroblastoma
88%
Neuroblastoma Cell
34%
Chronic Graft Versus Host Disease
27%
Cholinesterase
27%
Temsirolimus
25%
Pediatrics
24%
Neoplasm
21%
Malignant Neoplasm
20%
Pediatric Cancer
20%
In Vitro
20%
Medulloblastoma
18%
Receptor
18%
Protein Synthesis
18%
Cisplatin
17%
Disease
16%
Cell Growth
16%
Rapamycin
15%
Amino Acid
15%
Acute Graft Versus Host Disease
13%
mTOR Signaling
13%
Surveillance, Epidemiology, and End Results
12%
Graft Versus Host Reaction
12%
Norepinephrine Transporter
11%
Xenograft
10%
Biological Marker
10%
Autophagy
10%
Mammalian Target of Rapamycin Inhibitor
10%
Metabolomics
9%
Metastatic Carcinoma
9%
Carcinogenesis
9%
Cell Surface
9%
Public Health
9%
Trisomy 18
9%
Mammalian Target of Rapamycin
9%
2 Oxoglutaric Acid
9%
Vismodegib
9%
Chaperone
9%
Oncoprotein
9%
Juvenile Myelomonocytic Leukemia
9%
Mitoxantrone
9%
Parenteral Nutrition
9%
Infusion
9%
Evans Syndrome
9%
Iodine 131
9%
Cancer Radiotherapy
9%
Multivitamin
9%
Cancer Incidence
9%
Parenteral Solution
9%
Calcineurin
9%
Guanidine Derivative
9%
Keyphrases
Medulloblastoma
51%
Neuroblastoma
36%
Non-coding RNA (ncRNA)
28%
Pediatric Cancer
19%
In Cancer
19%
Butyrylcholinesterase (BChE)
18%
DsiRNA
18%
Modified siRNA
18%
Tumor
15%
Diagnostic Interventions
13%
Epigenetics
13%
Tumor Growth
13%
MicroRNA
11%
Epigenetic Regulation
10%
MYC Expression
10%
Polymeric Nanomedicines
10%
Cancer Therapy
9%
Therapy Resistance
9%
Group 3 Medulloblastoma
9%
Nephroblastomatosis
9%
Trisomy 18
9%
18q Duplication
9%
Tumor Screening
9%
STAT3 Inhibitor
9%
Polyplexes
9%
Second Allogeneic Transplant
9%
Juvenile Myelomonocytic Leukemia
9%
Brain Uptake
9%
Childhood Neuroblastoma
9%
227Th
9%
α-particle Therapy
9%
Protein Synthesis Pathway
9%
Growth in Vitro
9%
Weaver Syndrome
9%
Tissue Metabolism
9%
Cisplatin
9%
Protein Arginine Methyltransferase 5 (PRMT5)
9%
Anti-PD-1 Antibody
9%
Pediatric Hodgkin Lymphoma
9%
Fusion Gene
9%
Personalized Therapy
9%
Isaacs Syndrome
9%
N-phosphorylation
9%
IGF1R Signaling
9%
Temsirolimus
9%
Intestinal Transplant
9%
MTOR Inhibitor
9%
Murine Model
9%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
9%
MiR-1253
9%
